Cambridge is home to one of our global strategic R&D sites – The Discovery Centre (DISC), which is a state-of-the-art research facility and our global corporate HQ. The DISC is designed to play a central role in enabling the delivery of our science-led strategy, turning science into medicine. It is located at the heart of the Cambridge Biomedical Campus, one of Europe’s leading life sciences clusters. With access to world-class talent and opportunities for collaboration, being in Cambridge enables us to continue to focus on innovative science in our chosen therapy areas. At the same time, we’re committed to ensuring our company is a great place to work for the 4,000+ AstraZeneca employees located here. The scale of our collaboration with local partners is significant for our company and for patients. Currently we’re involved in over 200 partnerships across the Cambridge life sciences ecosystem and more than 130 active collaborations with the University of Cambridge. And here – as well as globally – partnerships and collaborations like this are pointing the way to the future as we focus on the discovery, development, and delivery of the next generation of life-changing medicines.